✦ LIBER ✦

A novel nutritional formula reduces corticosteroid requirements in patients with ulcerative colitis: A prospective, double-blinded, randomized, placebo controlled multicenter trial

✍ Scribed by Seidner, Douglas L.; Lashner, Bret A.; Brzezinski, Aaron; DeMichele, Stephen J.; Garleb, Keith A.

Book ID: 122632364
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 176 KB
Volume: 118
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(00)85269-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

389 A Randomized, Double-Blind, Placebo-

389 A Randomized, Double-Blind, Placebo-Controlled Trial of Basiliximab with Concomitant Corticosteroids in Steroid-Refractory Ulcerative Colitis

✍ Bruce E. Sands; William J. Sandborn; Tom J. Creed; Colin M. Dayan; Gert A. Van A 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Erythropoietin Treatment under Polychemo

Erythropoietin Treatment under Polychemotherapy in Patients with Gynecologic Malignancies: A Prospective, Randomized, Double-Blind Placebo-Controlled Multicenter Study

✍ Ch. Kurz; Ch. Marth; G. Windbichler; M. Lahousen; M. Medl; N. Vavra; P. Sevelda 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Rituximab in patients with primary progr

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

✍ Kathleen Hawker; Paul O'Connor; Mark S. Freedman; Peter A. Calabresi; Jack Antel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

## Abstract ## Objective Rituximab, a monoclonal antibody selectively depleting CD20+ B cells, has demonstrated efficacy in reducing disease activity in relapsing‐remitting multiple sclerosis (MS). We evaluated rituximab in adults with primary progressive MS (PPMS) through 96 weeks and safety thro

Efficacy of a Complex Homeopathic Medica

Efficacy of a Complex Homeopathic Medication (Sinfrontal) in Patients with Acute Maxillary Sinusitis: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial

✍ Dmitriy I. Zabolotnyi; Kyra C. Kneis; Andy Richardson; Reinhard Rettenberger; Ma 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 268 KB

P323 Sustained therapeutic benefit of ve

P323 Sustained therapeutic benefit of vedolizumab throughout 1 year in ulcerative colitis in GEMINI I, a randomized, placebo-controlled, double-blind, multicenter trial

✍ Sandborn, W.; Sands, B.; Rutgeerts, P.; Sankoh, S.; Rosario, M.; Milch, C.; Fox, 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 232 KB

A randomized, multicenter, double-blind,

A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis

✍ Robert Bissonnette; Kim Papp; Yves Poulin; Gilles Lauzon; Launa Aspeslet; Robert 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 167 KB